AXA Gulf Collaborates with AbbVie and Bayti to Launch Unique ‘Patient Support Program’ in the UAE

AXA customers who suffer from Immune Mediated Inflammatory Disease (IMID) such as Rheumatoid Arthritis to be provided comprehensive support including free consultation, education and home delivery of medicines.   

In a yet another industry first towards providing innovative healthcare services, AXA Gulf has launched a unique ‘Patient Support Program’ in the UAE that is focused on providing comprehensive support to patients suffering from IMID. The new program has been introduced in collaboration with AbbVie, a research-based biopharmaceutical company, where the deal was signed with AbbVie South Gulf represented by Sami Abi Nakhoul the General Manager, and Bayti Home Healthcare, a company dedicated to provide patients with the medication they require at home. The program was unveiled recently at an event that was attended by executives from Dubai Healthcare Authority and leading doctors from the UAE.

AXA Gulf’s newly introduced ‘Patient Support Program’ acknowledges the physical challenges that patients suffering from different IBD diseases and hence it has been designed to offer a host of valuable services that help the patient conveniently manage their treatment and recovery process. These include free consultation, education and timely delivery of prescribed medicines.

“AXA Gulf’s ‘Patient Support Program’ is aligned with many of the country’s health priorities that include management of chronic diseases, enhancing patient adherence with education and also delivering quality service that ensures customer satisfaction”, said  Dr. Mohamed Farghali, Head of Insurance Medical Regulations, Dubai Healthcare Authority.

“A seamless alignment between healthcare professionals, insurance companies and the pharmaceutical industry is key to address the various challenges posed by fast evolving diseases. The ‘Patient Support Program’ is a unique offering and has been designed to empower patients to effectively manage their disease progression, helps raise disease awareness amongst patients, and also supports patients during their recovery process”, said Dr. Sherif Mahmoud, Head of Healthcare at AXA Gulf. “Nearly 20 per cent of the UAE population suffers from Arthritis and the patients’ condition can get worse if not detected early. Education on early symptoms and management of the condition are hence key elements of the new ‘Patient Support Program’.

“At AXA Gulf we are committed to invest in collaborations that help us offer unique and value added services. We are confident that AXA customers in the UAE will benefit immensely from the ‘Patient Support Program’, which is also in line with the Dubai Health Authority’s vision to develop state of the art healthcare services in the Emirate” said Dr. Sherif Mahmoud 

Registration to the ‘Patient Support Program’ is simple as all AXA customers will be automatically registered with Bayti, who will start educating patients regarding the various aspects of the illness besides also offering free consultations and free home delivery of medication.

In the near future, AXA Gulf plans to launch more patient support programs to cover different types of diseases and offer the best healthcare solutions to its customers.

ABOUT THE AXA in the gulf

With a workforce of over 1,000 employees, 39 branches & retail shops region-wide, more than 1 million customers and 2014 gross written premium of over US$ 937 million, AXA is one of the largest international player in the GCC. Present in the region for more than 60 years, AXA in the Gulf offers a wide range of insurance products and services for corporate and individual customers. The company has been awarded Insurer of the Year for the 5th consecutive year in 2014 and Personal Lines insurer for the 3rd consecutive year in 2015 at the MENA Insurance Awards and best Motor insurance product by the Banker Middle East in both UAE & KSA.  

As part of AXA’s Corporate Responsibility and its commitment to building better understanding about the health risks faced by individuals and the society, the company achieved a new Guinness world record for the most blood cholesterol readings in 8 hours at a single venue.

Website: www.axa-gulf.com

ABOUT THE AXA GROUP

The AXA Group is a worldwide leader in insurance and asset management, with 157,000 employees serving 103 million clients in 59 countries. In 2014, IFRS revenues amounted to Euro 92.0 billion and IFRS underlying earnings to Euro 5.1 billion. AXA had Euro 1,277 billion in assets under management as of December 31, 2014. For the sixth year in a row, AXA has maintained its position as a leading global insurance brand, placing it among the world’s 100 Best Global Brands by Interbrand as well as the Best Global Green Brand in insurance, putting AXA in the top 50 of all global green brands.

Website: www.axa.com

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.